Gaurav Maini
Stock Analyst at LifeSci Capital
(0.17)
# 4,599
Out of 4,974 analysts
46
Total ratings
36.4%
Success rate
-24.6%
Average return
Main Sectors:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IKT Inhibikase Therapeutics | Reiterated: Buy | $5 | $2.31 | +116.45% | 6 | Sep 15, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | $6 | $6.88 | -12.79% | 13 | Sep 15, 2026 | |
| CTNM Contineum Therapeutics | Rated: Buy | $24 → $23 | $13.82 | +66.43% | 2 | Sep 14, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $28.51 | +208.66% | 9 | Aug 31, 2026 | |
| LQDA Liquidia | Downgraded: Hold | $101 → $90 | $65.72 | +36.94% | 6 | Aug 12, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $35 → $5 | $1.83 | +173.22% | 9 | Aug 10, 2026 | |
| CNTM ConnectM Technology Solutions, Inc. | Initiated Coverage: Buy | $24 | $4.97 | +383.29% | 1 | Jul 30, 2026 |
Inhibikase Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $5
Current: $2.31
Upside: +116.45%
Sionna Therapeutics
Sep 15, 2026
Reiterated: Hold
Price Target: $6
Current: $6.88
Upside: -12.79%
Contineum Therapeutics
Sep 14, 2026
Rated: Buy
Price Target: $24 → $23
Current: $13.82
Upside: +66.43%
Tectonic Therapeutic
Aug 31, 2026
Reiterated: Buy
Price Target: $88
Current: $28.51
Upside: +208.66%
Liquidia
Aug 12, 2026
Downgraded: Hold
Price Target: $101 → $90
Current: $65.72
Upside: +36.94%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $5
Current: $1.83
Upside: +173.22%
ConnectM Technology Solutions, Inc.
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $4.97
Upside: +383.29%